drugset / Trial / NCT00611195
Remifentanil and Laryngeal Reflex Responses in Pediatric Patients With URI
NaSingle-groupOpen-labelPrevention
Summary
To describe respiratory and laryngeal responses to laryngeal stimulation during propofol anesthesia in children with upper airway infections. To determine whether the co-administration of remifentanil blunts these reflex responses. To test whether the co-administration of remifentanil results in a significant reduction of apnea with laryngospasm in these patients. Hypotheses: I: In children with a URI undergoing anesthesia with propofol, the incidence of apnea and laryngospasm after controlled stimulation is expected to occur 2.5 times more frequently than in children without URI (20 vs. 8%). II: The incidence of apnea and laryngospasm is diminished after administration of remifentanil.
Timeline
- Start
- 2008-01
- Primary completion
- 2012-10
- Completion
- 2012-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Remifentanil | Small molecule | 0.05 ug/kg | — |
| Background | Propofol | Small molecule | 3 ug/ml | — |